NeXT Personal Detects High Relapse Risk in Breast Cancer Patients
June 3, 2025
Personalis, Inc., a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting